NOT KNOWN FACTUAL STATEMENTS ABOUT SEMAGLUTIDE WEEK 1-6 BUNDLE

1) and Drug Interactions (7)]. The risk of hypoglycemia can be reduced by a reduction within the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Advise patients utilizing these concomitant medications of the chance of hypoglycemia and educate them within the signals and symptoms of hypoglycemia.Assuming t